iSpecimen Inc. Increase (Decrease) in Prepaid Expense and Other Assets
iSpecimen Inc. (ISPC) reported Increase (Decrease) in Prepaid Expense and Other Assets of $23.48 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$483.25K, a 1275.71% decline year-over-year.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $506.74K.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$627.55K.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $493.20K, a 1132.53% increase year-over-year.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$194.32K.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$27.19K.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$8.36K.
- iSpecimen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$26.60K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$483.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.48K 10-Q · filed 2026-08-14 | -$604.07K derived: sum of 3 quarters · filed 2026-08-14 | -$110.88K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $506.74K 10-Q · filed 2026-05-18 | -$120.82K derived: sum of 2 quarters · filed 2026-05-18 | $372.38K derived: sum of 3 quarters · filed 2026-05-18 | $413.48K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$627.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$134.36K derived: sum of 2 quarters · filed 2026-04-01 | -$93.26K derived: sum of 3 quarters · filed 2026-08-14 | -$194.32K 10-K · filed 2026-04-01 |
| 2025-09-30 | $493.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $534.30K derived: sum of 2 quarters · filed 2026-08-14 | $433.23K 10-Q · filed 2025-11-17 | $420.54K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $41.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$59.97K 10-Q · filed 2026-08-14 | -$72.65K derived: sum of 3 quarters · filed 2026-08-14 | -$32.64K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$101.07K 10-Q · filed 2026-05-18 | -$113.76K derived: sum of 2 quarters · filed 2026-05-18 | -$73.74K derived: sum of 3 quarters · filed 2026-05-18 | -$150.18K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$12.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $27.33K derived: sum of 2 quarters · filed 2026-04-01 | -$49.11K derived: sum of 3 quarters · filed 2026-04-01 | -$27.19K 10-K · filed 2026-04-01 |
| 2024-09-30 | $40.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$36.42K derived: sum of 2 quarters · filed 2025-11-17 | -$14.50K 10-Q · filed 2025-11-17 | -$43.03K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$76.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$54.52K 10-Q · filed 2025-08-14 | -$83.05K derived: sum of 3 quarters · filed 2025-08-14 | $49.80K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $21.92K 10-Q · filed 2025-05-19 | -$6.61K derived: sum of 2 quarters · filed 2025-05-19 | $126.23K derived: sum of 3 quarters · filed 2025-05-19 | $1.10K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$28.53K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $104.31K derived: sum of 2 quarters · filed 2025-04-14 | -$20.82K derived: sum of 3 quarters · filed 2025-04-14 | -$8.36K 10-K · filed 2025-04-14 |
| 2023-09-30 | $132.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.71K derived: sum of 2 quarters · filed 2024-11-07 | $20.18K 10-Q · filed 2024-11-07 | -$20.94K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$125.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$112.67K 10-Q · filed 2024-08-06 | -$153.79K derived: sum of 3 quarters · filed 2024-08-06 | -$187.10K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $12.47K 10-Q · filed 2024-05-07 | -$28.66K derived: sum of 2 quarters · filed 2024-05-07 | -$61.97K derived: sum of 3 quarters · filed 2024-05-07 | $17.15K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$41.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$74.43K derived: sum of 2 quarters · filed 2024-03-13 | $4.68K derived: sum of 3 quarters · filed 2024-03-13 | -$26.60K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$33.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $45.80K derived: sum of 2 quarters · filed 2023-11-02 | $14.52K 10-Q · filed 2023-11-02 | -$117.77K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $79.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $47.83K 10-Q · filed 2023-08-02 | -$84.45K derived: sum of 3 quarters · filed 2023-08-02 | -$67.22K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$31.29K 10-Q · filed 2023-05-04 | -$163.57K derived: sum of 2 quarters · filed 2023-05-04 | -$146.34K derived: sum of 3 quarters · filed 2023-05-04 | -$132.33K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$132.29K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$115.05K derived: sum of 2 quarters · filed 2023-03-30 | -$101.05K derived: sum of 3 quarters · filed 2023-03-30 | -$90.89K 10-K/A · filed 2023-03-30 |
| 2021-09-30 | $17.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $31.24K derived: sum of 2 quarters · filed 2022-11-08 | $41.39K 10-Q · filed 2022-11-08 | $260.80K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $14.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $24.16K 10-Q · filed 2022-08-04 | $243.56K derived: sum of 3 quarters · filed 2022-08-04 | $247.04K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $10.15K 10-Q · filed 2022-05-10 | $229.56K derived: sum of 2 quarters · filed 2022-05-10 | $233.04K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $219.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $222.88K derived: sum of 2 quarters · filed 2022-03-22 | $226.37K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $3.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.97K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $3.49K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |